Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT02081378 |
Title | A Phase I Study of Oral ABL001 in Patients With CML or Ph+ ALL |
Recruitment | Completed |
Gender | both |
Phase | Phase I |
Variant Requirements | Yes |
Sponsors | Novartis Pharmaceuticals |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA | NLD | ITA | FRA | ESP | DEU | AUS |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Dana Farber Cancer Institute Hematology / Oncology | Boston | Massachusetts | 02215 | United States | Details | |
University of Michigan Comprehensive Cancer Center SC | Ann Arbor | Michigan | 48109 | United States | Details | |
Memorial Sloan Kettering Cancer Center Memorial Sloan Kettering | New York | New York | 10065 | United States | Details | |
Oregon Health Sciences University SC-6 | Portland | Oregon | 97239 | United States | Details | |
University of Texas/MD Anderson Cancer Center UT MD Anderson | Houston | Texas | 77030-4009 | United States | Details | |
Huntsman Cancer Institute SC | Salt Lake City | Utah | 84112 | United States | Details | |
Novartis Investigative Site | Adelaide | South Australia | 5000 | Australia | Details | |
Novartis Investigative Site | Paris 10 | Cedex 10 | 75475 | France | Details | |
Novartis Investigative Site | Bordeaux | 33076 | France | Details | ||
Novartis Investigative Site | Berlin | 13353 | Germany | Details | ||
Novartis Investigative Site | Frankfurt | 60590 | Germany | Details | ||
Novartis Investigative Site | Jena | 07740 | Germany | Details | ||
Novartis Investigative Site | Roma | RM | 00161 | Italy | Details | |
Novartis Investigative Site | Kobe-shi | Hyogo | 650-0017 | Japan | Details | |
Novartis Investigative Site | Seoul | Seocho Gu | 06591 | Korea, Republic of | Details | |
Novartis Investigative Site | Amsterdam | 1081 HV | Netherlands | Details | ||
Novartis Investigative Site | Singapore | 169608 | Singapore | Details | ||
Novartis Investigative Site | Madrid | 28006 | Spain | Details |